BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38610554)

  • 21. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors.
    Peng G; Hakim M; Broza YY; Billan S; Abdah-Bortnyak R; Kuten A; Tisch U; Haick H
    Br J Cancer; 2010 Aug; 103(4):542-51. PubMed ID: 20648015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration of the Exhaled Volatile Organic Compound Pattern in Colorectal Cancer Patients after Intentional Curative Surgery-A Prospective Pilot Study.
    Hanevelt J; Schoenaker IJH; Brohet RM; Schrauwen RWM; Baas FJN; Tanis PJ; van Westreenen HL; de Vos Tot Nederveen Cappel WH
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
    Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer screening with odour material by canine scent detection.
    Sonoda H; Kohnoe S; Yamazato T; Satoh Y; Morizono G; Shikata K; Morita M; Watanabe A; Morita M; Kakeji Y; Inoue F; Maehara Y
    Gut; 2011 Jun; 60(6):814-9. PubMed ID: 21282130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis.
    Hanna GB; Boshier PR; Markar SR; Romano A
    JAMA Oncol; 2019 Jan; 5(1):e182815. PubMed ID: 30128487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exhaled volatile organic compounds identify patients with colorectal cancer.
    Altomare DF; Di Lena M; Porcelli F; Trizio L; Travaglio E; Tutino M; Dragonieri S; Memeo V; de Gennaro G
    Br J Surg; 2013 Jan; 100(1):144-50. PubMed ID: 23212621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real Time Breath Analysis Using Portable Gas Chromatography for Adult Asthma Phenotypes.
    Sharma R; Zang W; Zhou M; Schafer N; Begley LA; Huang YJ; Fan X
    Metabolites; 2021 Apr; 11(5):. PubMed ID: 33922762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Targeted and Untargeted Approaches in Breath Analysis for the Discrimination of Lung Cancer from Benign Pulmonary Diseases and Healthy Persons.
    Koureas M; Kalompatsios D; Amoutzias GD; Hadjichristodoulou C; Gourgoulianis K; Tsakalof A
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33946997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection.
    Chen X; Muhammad KG; Madeeha C; Fu W; Xu L; Hu Y; Liu J; Ying K; Chen L; Yurievna GO
    Lung Cancer; 2021 Apr; 154():197-205. PubMed ID: 33653598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis by Volatile Organic Compounds in Exhaled Breath in Exhaled Breath from Patients with Gastric and Colorectal Cancers.
    Chung J; Akter S; Han S; Shin Y; Choi TG; Kang I; Kim SS
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
    Oakley-Girvan I; Davis SW
    Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions.
    Xu ZQ; Broza YY; Ionsecu R; Tisch U; Ding L; Liu H; Song Q; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD; Leja M; Haick H
    Br J Cancer; 2013 Mar; 108(4):941-50. PubMed ID: 23462808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exhaled VOCs can discriminate subjects with COVID-19 from healthy controls.
    Woollam M; Angarita-Rivera P; Siegel AP; Kalra V; Kapoor R; Agarwal M
    J Breath Res; 2022 May; 16(3):. PubMed ID: 35453137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.
    Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W
    Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.
    Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD
    J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis.
    Arasaradnam RP; McFarlane MJ; Ryan-Fisher C; Westenbrink E; Hodges P; Thomas MG; Chambers S; O'Connell N; Bailey C; Harmston C; Nwokolo CU; Bardhan KD; Covington JA
    PLoS One; 2014; 9(9):e108750. PubMed ID: 25268885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of breast cancer risk with volatile biomarkers in breath.
    Phillips M; Cataneo RN; Cruz-Ramos JA; Huston J; Ornelas O; Pappas N; Pathak S
    Breast Cancer Res Treat; 2018 Jul; 170(2):343-350. PubMed ID: 29569019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.